menu toggle
Friday, November 28
Our offices will also be closed on Friday, November 28. While some deliveries will take place on Friday according to network operations, our Customer Service and Customer Systems Support teams will be unavailable. Please review our full holiday schedule for more detailed information and to plan your orders accordingly.
Action required: New logo and email address for invoices starting October 18
Ensure that you’re prepared to continue receiving invoices electronically.

September 15, 2025

Now available Octreotide Acetate Injection Kit

Octreotide acetate for injectable suspension is a somatostatin analogue indicated for: Treatment in patients who have responded to and tolerated octreotide acetate injection subcutaneous injection for:

  • Acromegaly
  • Severe diarrhea/flushing episodes associated with metastatic carcinoid tumors
  • Profuse watery diarrhea associated with Vasoactive Intestinal Peptide (VIP) secreting tumors

Octreotide acetate for injectable suspension is an FDA-approved ANDA generic.

Please see full prescribing information here.